Healthcare
Live Price
Offline$0.1349
+0.00% today
1Y Change
-32.60%
Window
Jun 23, 2025 → Jun 15, 2026
Coverage: 253 bars · Jun 23, 2025 → Jun 15, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Viva Biotech Holdings (VBIZF) is a Healthcare stock with a market cap of $3.11B and listed on OTC. The stock last traded around $0.13 and down 32.6% across the available one-year price window (Jun 23, 2025 → Jun 15, 2026). Baseline metrics include revenue growth of -15.2%, EPS growth of +27.7%, a dividend yield of 0.0%. What stands out right now is revenue -15.2%, EPS +27.7%, free cash flow -51.7% with operating margin 11.2% and ROIC 2.4%. Valuation is more restrained than many high-expectation growth names at P/E 6.4 and price/sales 1.8. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines VBIZF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
VBIZF
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
VBIZF Max Drawdown
-65.07%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for VBIZF and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
| Ex-Date | Record | Pay | Dividend | Adj | Frequency |
|---|---|---|---|---|---|
| Jun 16, 2021 | Jun 18, 2021 | Jul 9, 2021 | $0.00 | $0.00 | Semi-Annual |
| Sep 11, 2020 | Sep 15, 2020 | Oct 6, 2020 | $0.00 | $0.00 | Semi-Annual |
| Jun 15, 2020 | Jun 17, 2020 | Jul 10, 2020 | $0.00 | $0.00 | Semi-Annual |
| Sep 9, 2019 | Sep 10, 2019 | Sep 30, 2019 | $0.00 | $0.00 | Semi-Annual |
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.